Chemical | 13 February 2021
UFlex Q3FY 21 PAT up 89%
The company is setting up greenfield BOPET and CPP lines in Karnataka to meet the growing demand.
The company is setting up greenfield BOPET and CPP lines in Karnataka to meet the growing demand.
The company has posted net profit of Rs.2301.31 crores for the 9 months period ended December 31, 2020
The company continued to maintain clear FDA status across its plants and has received 12 ANDA approvals during 9MFY21
Jubilant announced the completion of demerger of pharma and LSI business into two separate companies
The company posted net profit of Rs.35.82 crores for the period ended December 31, 2019.
The company has posted net profit loss of Rs. 3.78 crores for the period ended December 31, 2019.
The company posted net profit loss of Rs.1.12 crores for the period ended December 31, 2019.
The company s posted net loss of Rs. 1.38 crores for the period ended December 31, 2019.
It posted net profit of Rs.9.28 crores for the period ended December 31, 2019.
The company posted net profit of Rs.683.94 crores for the period ended December 31, 2019.
The company posted net profit of Rs.25.37 crores for the period ended December 31, 2019.
Pfizer Limited (PFL) reported an operationally strong performance in the quarter. Revenue grew 10.3% YoY to Rs6.0bn (I-Sec: Rs6.0bn) as company is benefiting from its vitamins / minerals / nutrients (VMN) portfolio in the current environment. EBITDA margin jumped 840bps YoY to 33.2% (I-Sec: 29.8%) driven by lower S, G&A costs and adjusted PAT grew 25.2% YoY to Rs1.4bn.
The centralized marketing authorization granted by the EC is valid in all EU Member
The new facility further expands the company’s capacity and reinforces its leading supply position in Penang to serve the fast-growing customer demand from the electrical and electronics (E&E) and other manufacturing industries
The pandemic has provided tailwinds in terms of access to rural healthcare and India’s emergence as a vaccine powerhouse
.jpg)
The company's gas sales volume has shown a robust recovery post lockdown.
Among subsidiaries, Marpol and Perma grew in high double digits.
The medical device Sector in India suffers from a considerable cost of manufacturing disability.
The Cabinet Committee on Economic Affairs accorded approval to the proposal of the Department of Fertilizers for Grant-in-aid of Rs.100 crore to BVFCL
According to IQVIA sales data for the 12 month period ending December 2020, the Cleocin T Gel, 1% market achieved annual sales of approximately $73.8 million.
Subscribe to our newsletter & stay updated.
